
Our friend Connie Johncock
METUPUK are devastated by the news that one of our Trustees and friend Connie Johncock has died. Connie was a founder trustee of METUPUK and our Treasurer, overseeing our finances as we became…
Read more
All our latest news, campaign updates and blog posts from the METUPUK team and the wider MBC community.

METUPUK are devastated by the news that one of our Trustees and friend Connie Johncock has died. Connie was a founder trustee of METUPUK and our Treasurer, overseeing our finances as we became…
Read more

Hi. My name is Gita and I have been a Therapeutic Radiographer for nearly 30 years. I’d like to share my professional and personal experiences of treating both primary and secondary breast cancer.
Read more

The Scottish Medicines Consortium (SMC) have decided against funding the metastatic breast cancer drug alpelisib (Piqray).
Read more

We had to confirm back on the 5th November the heartbreaking news that the wonderful Philippa Hetherington had died 💔 She was an absolute force of intellectual nature for breast cancer in general,…
Read more

*METUPUK are delighted for the approval of Trastuzumab deruxtecan (Enhertu) for treating HER2-positive unresectable or metastatic breast cancer in adults who have received one or more prior anti-HER2…
Read more

If a person has a heart attack, do they get told that they will never have a heart attack again and they are free of heart disease?
Read more

METUPUK was over the moon to receive an amazing donation from Hearts & Hope 4 Helen. The cheque was handed over to METUPUK at the Darker Pink exhibition, which is currently in the Michell Library in…
Read more
METUPUK welcomes the Scottish Medicines Consortium (SMC) decision to accept pembrolizumab (Keytruda, Merck Sharp and Dohme) plus chemotherapy (paclitaxel or nab-paclitaxel) for use on the NHS in…
Read more

METUPUK welcomes the approval of Piqray (alpelisib) plus fulvestrant for the treatment of hormone receptor-positive, HER2-negative, PIK3CA- mutated advanced breast cancer. Piqray is an exciting new…
Read more

METUPUK are delighted that NICE has accepted Trodelvy (sacituzumab govitecan) for routine use on the NHS in England for the treatment of patients with unresectable locally advanced or metastatic…
Read more

Today we want to honour our friend and MetUpUK member Emma Hillier.
Read more

A new campaign in Wales, by MetUpUK member Tassia Haines, aims to draw attention to the fact that Metastatic Breast Cancer (MBC) patients feel that they are being failed by the Welsh Government.
Read more